European product
CE marking
MDR certification
Backed by clinical trials
Private label available
OpHLINE 1.4% PROTECTION
1.4% high-molecular-weight hyaluronic acid viscoelastic solution.
Maximum protection of the corneal endothelium and complete removal at the end of surgery.
- Concentration
- 1.4%
- Presentation
- 1.2 mL prefilled syringe + injection cannula
- Certification
- Medical Device
- Recommended cannula
- 27G
- Shelf life
- 2 years
- Technology
- Linear sodium hyaluronate hydrogel.
Visibilidad óptima
Libre de látex
Extracción segura
Sin burbujas
Advantages
- Larger volume (1.2 mL).
- No refrigeration required.
- HA obtained through biofermentation.
- Manufactured in Europe to demanding quality standards.
Indications
Indicated as an adjunct during surgical procedures involving the anterior chamber of the eye, particularly cataract surgery, for maximum protection of the corneal endothelium and complete removal at the end of surgery.
Properties
- Acts as an adjunct in ophthalmic surgery.
- Protects intraocular tissues, facilitating surgery.
- Is easy to remove from the anterior chamber.
- Provides excellent visibility of the surgical field.
Directions for use
For administration only by healthcare professionals specialising in ophthalmology, in accordance with all rules governing aseptic procedure and injection technique to ensure treatment safety and efficacy.
Technology
Linear sodium hyaluronate hydrogel.
- Larger volume (1.2 mL).
- No refrigeration required.
- HA obtained through biofermentation.
- Manufactured in Europe to demanding quality standards.
Productos relacionados
OpHLINE 1.4% PROTECTION
Maximum protection of the corneal endothelium and complete removal at the end of surgery.
OpHLINE 2% VERSATILE
Stable maintenance of the anterior chamber space together with effective protection of the corneal endothelium.
OpHLINE 3.0% SPACE
Maximum maintenance of anterior chamber space and stability throughout the procedure.